Cellebrite DI Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cellebrite DI Ltd. (CLBT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents191.66189.5287.65181.57128.71
Short-Term Investments255.56113.4195.9835.59108.93
Cash & Short-Term Investments447.22302.92183.62181.57237.64
Accounts Receivable82.3677.2778.7667.5166.32
Inventory8.949.9410.186.514.75
Other Current Assets9.518.898.493.244.32
Total Current Assets567.59422.08295.93273.21324.27
Non-Current Assets
Property, Plant & Equipment (Net)27.6030.1632.9116.7616.11
Long-Term Investments36.6028.8622.130.000.00
Goodwill28.7126.8326.8326.839.46
Intangible Assets11.3110.5911.2511.236.61
Other Non-Current Assets7.687.341.731.960.57
Total Non-Current Assets122.97110.80107.3666.570.00
Total Assets690.57532.89403.29339.78364.39
Current Liabilities
Accounts Payable11.088.284.6163.594.73
Short-Term Debt4.130.000.000.000.00
Accrued Liabilities60.0442.9239.7442.5341.33
Deferred Revenue216.97195.73153.34123.68105.54
Other Current Liabilities2.531.0920.0244.711.18
Total Current Liabilities295.50253.82207.78186.57159.38
Non-Current Liabilities
Long-Term Debt6.8454.1210.350.000.00
Other Non-Current Liabilities6.95188.5949.1188.576.56
Total Non-Current Liabilities59.05244.85121.65226.560.00
Total Liabilities354.55498.67329.43413.13199.38
Stockholders' Equity
Retained Earnings-164.86118.14199.2478.4428.34
Accumulated Other Comprehensive Income500.97-83.850.331.371.32
Treasury Stock0.09-0.090.09-0.090.00
Additional Paid-in Capital498.88-84.90-125.62-153.070.00
Shares Outstanding234.52203.23193.01187.680.00
Total Stockholders' Equity336.0234.2173.87-73.35165.01
Total Liabilities & Equity690.57532.89403.29339.780.00